https://uwaterloo.ca/research/waterloo-commercialization-off...
Many of the big giants of tech world have set up offices all around uWaterloo and enjoy a symbiotic relationship w/ the research faculty.
The only annoyance is that the 1/3rd comes from the University's profits, not revenue. The costs of the patent application, including the tech-transfer office salaries, are subtracted first.
Commercializing IP - which is not a product yet - is non-trivial, could take years to productize, and then longer to penetrate (or create) a market. In short, it's a long, painful, and often expensive process that often fails anyway. If there was a way to provide a license agreement that was more favorable to product/market validation, that could change the economics.
Unfortunately, I've only participated in licensing once, so I don't have an alternative model to suggest.
(a) The papers were published in journals like - Journal of Green Donkey Testicles, Journal of differentiation of dying mouse ... Journals that I had never heard of, had no impact and every tiny bit of an experiment that was conducted in the lab, would get published, without a full picture.
(b) Much of the data was turned into data by turning everything into being 'statistically significant' . I would do experiments and I would see no freaking difference between control and experimental, yet, through the magic of statistics, she would find the difference. It was lame and depressing.
(c) Above is an isolated example. There are countless smart, diligent and hard working professors who continue to push the boundaries of science (ex. my amazing PhD prof, whom I dearly love and admire). Unfortunately, their time is plagued by writing grants after grants, fighting inter-departmental politics, dealing with Chair of the department on regular basis ... basically stuff that distracts them from having the time to relax, think and innovate.
(d) Commercialization of innovations in schools and universities are butchered by the IP policies, where by the University would take 1/3, the commercialization office would take 1/3 and the poor researcher is left with the rest. This kills innovation + tech commercialization and the desire of a researcher to be an entrepreneur.